Hypertriglyceridemia (HG) is an independent risk factor with more prevalence than hypercholesterolemia and its attributes to cardiovascular disease (CVD) and pancreatitis. Hence, it becomes imperative to search for new triglyceride (TG) lowering agents. Tinospora cordifolia (TC) is a well-known Ayurvedic drug and a rich source of protoberberine alkaloids hence can contribute to TG lowering without side effects. Hence, to explore the therapeutic efficacy of T. cordifolia and its effects on biochemistry and metabolome in the patients of hyper-triglyceridemia, clinical trials were conducted.
Patients (n = 24) with hypertriglyceridemia were randomized into two groups to receive T. cordifolia extract (TCE) (3.0 g/per day) and metformin (850 mg/day) for 14 days having >300 mg/dl triglyceride level and cholesterol in the range of 130–230 mg/dl. Lipid profiles of blood samples were analyzed. Urine samples were subjected to HPLC-QTOF-MS to quantify oxidative damage and abnormal metabolic regulation.
Intervention with TCE reduced the triglyceride, LDL, and VLDL levels to 380.45 ± 17.44, 133.25 ± 3.18, and 31.85 ± 5.88 mg/dL and increased the HDL to 47.50 ± 9.05 mg/dL significantly (p < 0.05) in the HG patients after 14 days treatment. TCE dosage potently suppressed the inflammatory and oxidative stress marker’s i.e. levels of isoprostanes significantly (p < 0.01). Qualitative metabolomics approach i.e. PCA and PLS-DA showed significant alterations (p < 0.05) in the levels of 40 metabolites in the urine samples from different groups.
TCE administration depleted the levels of markers of HG i.e. VLDL, TG, and LDL significantly. Metabolomics studies established that the anti-HG activity of TCE was due to its antioxidative potential and modulation of the biopterin, butanoate, amino acid, and vitamin metabolism.
Clinical trials registry
India (CTRI) registration no. CTRI- 2016-08-007187.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Peroxisome proliferator-activated receptors
Partial least-squares-discriminant analysis
Rapid Resolution Liquid Chromatography
Electrospray Ionization Quadrupole Time of Flight Mass Spectrometry
Tinospora cordifolia Extract
Upadhyay A, Kumar K, Kumar A, Mishra H. Tinospora cordifolia (Willd.) Hook. f. and Thoms. (Guduchi) -validation of the Ayurvedic pharmacology through experimental and clinical studies. Int J Ayurveda Res. 2010:112.
Pathak P, Vyas M, Vyas H, Naria M. Rasayana effect of Guduchi Churna on the life span of Drosophila melanogaster. AYU (An Int Q J Res Ayurveda). 2016;37:67.
Haque MA, Jantan I, Abbas Bukhari SN. Tinospora species: an overview of their modulating effects on the immune system. J Ethnopharmacol. 2017:67–85.
Sannegowda KM, Venkatesha SH, Moudgil KD. Tinospora cordifolia inhibits autoimmune arthritis by regulating key immune mediators of inflammation and bone damage. Int J Immunopathol Pharmacol. 2015;28(4):521–31.
Sharma B, Dabur R. Protective effects of Tinospora cordifolia on hepatic and gastrointestinal toxicity induced by chronic and moderate alcoholism. Alcohol Alcohol. 2015;51:1–10.
Parveen A, Wang YH, Fantoukh O, Alhusban M, Raman V, Ali Z, et al. Development of a chemical fingerprint as a tool to distinguish closely related Tinospora species and quantitation of marker compounds. J Pharm Biomed Anal. 2020;178:112894.
Bajpai V, Kumar S, Singh A, Bano N, Pathak M, Kumar N, et al. Metabolic fingerprinting of dioecious Tinospora cordifolia (Thunb) Miers stem using DART TOF MS and differential pharmacological efficacy of its male and female plants. Ind Crop Prod. 2017;101:46–53.
Bhalerao BM, Vishwakarma KS, Maheshwari VL. Tinospora cordifolia (Willd.) Miers ex Hook.f. & Thoms.-plant tissue culture and comparative chemo-profiling study as a function of different supporting trees. Indian J Nat Prod Resour. 2013;4:380–6.
Tiwari M, Dwivedi UN, Kakkar P. Tinospora cordifolia extract modulates COX-2, iNOS, ICAM-1, pro-inflammatory cytokines and redox status in murine model of asthma. J Ethnopharmacol. 2014;153(2):326–37.
Reddy SS, Ramatholisamma P, Karuna R, Saralakumari D. Preventive effect of Tinospora cordifolia against high-fructose diet-induced insulin resistance and oxidative stress in male Wistar rats. Food Chem Toxicol. 2009;47(9):2224–9.
Singh H, Sharma AK, Gupta M, Singh AP, Kaur G. Tinospora cordifolia attenuates high fat diet-induced obesity and associated hepatic and renal dysfunctions in rats. PharmaNutrition. 2020;26:100189.
Baskaran R, Priya LB, Kumar VS, Padma VV. Tinospora cordifolia extract prevents cadmium-induced oxidative stress and hepatotoxicity in experimental rats. J Ayurveda Integr Med. 2018;9(4):252–7.
Kosaraju J, Chinni S, Roy PD, Kannan E, Antony AS, Kumar MS. Neuroprotective effect of Tinospora cordifolia ethanol extract on 6-hydroxy dopamine induced parkinsonism. Indian J Pharmacol. 2014;46(2):176–80.
Rege NN, Thatte UM, Dahanukar SA. Adaptogenic properties of six rasayana herbs used in Ayurvedic medicine. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives. 1999;13(4):275–91.
Kuchay MS, Farooqui KJ, Bano T, Khandelwal M, Gill H, Mithal A. Heparin and insulin in the management of hypertriglyceridemia-associated pancreatitis: Case series and literature review. Arch Endocrinol Metab. 2017:198–201.
Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, et al. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. N Engl J Med. 2019;380:11–22.
Chu AHY, Moy FM. Joint association of sitting time and physical activity with metabolic risk factors among middle-aged Malays in a developing country: a cross-sectional study. PLoS One. 2013;8.
Hasani-Ranjbar S, Jouyandeh Z, Abdollahi M. A systematic review of anti-obesity medicinal plants – an update. J Diabetes Metab Disord. 2013.
Shirolkar A, Gahlaut A, Hooda V, Dabur R. Phytochemical composition changes in untreated stem juice of Tinospora cordifolia (W) Mier during refrigerated storage. J Pharm Res. 2013;7:1–6.
Chernushevich IV, Loboda AV, Thomson BA. An introduction to quadrupole-time-of-flight mass spectrometry. J Mass Spectrom. 2001;36:849–65.
Shirolkar A, Sharma B, Lata S, Dabur R. Guduchi Sawras (Tinospora cordifolia): an Ayurvedic drug treatment modulates the impaired lipid metabolism in alcoholics through dopaminergic neurotransmission and anti-oxidant defense system. Biomed Pharmacother. 2016;83:1265–77.
Aoyagi K. Inhibition of arginine synthesis by urea: a mechanism for arginine deficiency in renal failure which leads to increased hydroxyl radical generation. InGuanidino Compounds in Biology and Medicine. 2003:11–5.
Pacana T, Cazanave S, Verdianelli A, Patel V, Min HK, Mirshahi F, et al. Dysregulated hepatic methionine metabolism drives homocysteine elevation in diet-induced nonalcoholic fatty liver disease. PLoS One. 2015;10:e0136822.
Singh R, Devi S, Gollen R. Role of free radical in atherosclerosis, diabetes and dyslipidaemia: larger-than-life. Diabetes Metab Res Rev. 2015;31(2):113–26.
Radosinska J, Bacova B, Bernatova I, Navarova J, Zhukovska A, Shysh A, et al. Myocardial NOS activity and connexin-43 expression in untreated and omega-3 fatty acids-treated spontaneously hypertensive and hereditary hypertriglyceridemic rats. Mol Cell Biochem. 2011;347(1–2):163–73.
Tejero J, Stuehr D. Tetrahydrobiopterin in nitric oxide synthase. IUBMB Life. 2013;65(4):358–65.
Mortensen PB. Formation and degradation of dicarboxylic acids in relation to alterations in fatty acid oxidation in rats. Biochim Biophys Acta (BBA)/Lipids Lipid Metab. 1992;1124:71–9.
Zhang W, He H, Wang H, Wang S, Li X, Liu Y, et al. Activation of transsulfuration pathway by salvianolic acid a treatment: a homocysteine-lowering approach with beneficial effects on redox homeostasis in high-fat diet-induced hyperlipidemic rats. Nutr Metab. 2013;10(1):1–1.
Montuschi P, Barnes PJ, Roberts LJ. Isoprostanes: markers and mediators of oxidative stress. FASEB J [Internet]. 2004;18:1791–800.
Milne GL, Musiek ES, Morrow JD. F2-isoprostanes as markers of oxidative stress in vivo: an overview. Biomarkers. 2005:10–23.
van’t Erve TJ, Kadiiska MB, London SJ, Mason RP. Classifying oxidative stress by F2-isoprostane levels across human diseases: a meta-analysis. Redox Biol. 2017;12:582–99.
Bifari F, Nisoli E. Branched-chain amino acids differently modulate catabolic and anabolic states in mammals: a pharmacological point of view. Br J Pharmacol. 2017:1366–77.
Neinast MD, Jang C, Hui S, Murashige DS, Chu Q, Morscher RJ, et al. Quantitative analysis of the whole-body metabolic fate of branched-chain amino acids. Cell Metab. 2019;29:417–29.
Arany Z, Neinast M. Branched chain amino acids in metabolic disease. Curr Diab Rep. 2018;18(10):76.
Kametani T, Koshida H, Nagaoka T, Miyakoshi H. Hypertriglyceridemia is an independent risk factor for development of impaired fasting glucose and diabetes mellitus: a 9-year longitudinal study in Japanese. Inter Med. 2002;41:516–21.
Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. The hypertriglyceridemia is associated with isolated impaired glucose tolerance in subjects without insulin resistance. Endocr Res. 2015;40:70–3.
Mook-Kanamori DO, Römisch-Margl W, Kastenmüller G, Prehn C, Petersen AK, Illig T, et al. Increased amino acids levels and the risk of developing of hypertriglyceridemia in a 7-year follow-up. J Endocrinol Investig. 2014;37:369–74.
Nie C, He T, Zhang W, Zhang G, Ma X. Branched chain amino acids: beyond nutrition metabolism. Int J Mol Sci. 2018;19.
Newgard CB. Interplay between lipids and branched-chain amino acids in development of insulin resistance. Cell Metab. 2012:606–14.
Abdoli N, Azarmi Y, Eghbal MA. Mitigation of statins-induced cytotoxicity and mitochondrial dysfunction by L-carnitine in freshly-isolated rat hepatocytes. Res Pharm Sci. 2015;10:143–51.
Noipha K, Ratanachaiyavong S, Purintrapiban J, Herunsalee A, Ninla-Aesong P. Effect of Tinospora crispa on glucose uptake in skeletal muscle: role of glucose transporter 1 expression and extracellular signal-regulated kinase1/2 activation. Asian Biomed. 2011;5:361–9.
El-Hattab AW, Scaglia F. Disorders of carnitine biosynthesis and transport. Mol Genet Metab. 2015:107–12.
Kersten S, Stienstra R. The role and regulation of the peroxisome proliferator activated receptor alpha in human liver. Biochimie. 2017:75–84.
Authors wish to acknowledge the CCRAS, Ministry of AYUSH, Govt of India for supporting the work.
Human Ethics Committee of the PDDYP Ayurveda College, Pune, India approved the study wide letter no. RRI/2011/HEC/2023 dated 18-02-2011.
Conflict of interest
All authors declare that they have no conflict of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
About this article
Cite this article
Shirolkar, A., Yadav, A., Mandal, T.K. et al. Intervention of Ayurvedic drug Tinospora cordifolia attenuates the metabolic alterations in hypertriglyceridemia: a pilot clinical trial. J Diabetes Metab Disord (2020). https://doi.org/10.1007/s40200-020-00657-3
- Tinospora cordifolia